Bayreuth, Germany

Aggelos Nikolopoulos


Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Aggelos Nikolopoulos: Innovator in Pharmaceutical Chemistry

Introduction

Aggelos Nikolopoulos is a notable inventor based in Bayreuth, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the preparation of ranitidine hydrochloride.

Latest Patents

Nikolopoulos holds a patent for a process titled "Process for preparing form 1 ranitidine hydrochloride." This innovative method involves preparing pure N-[2-[[[5-[dimethylamino)-methyl-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethyldiamine hydrochloride, designated as Form 1 ranitidine hydrochloride. The process utilizes ranitidine in methylene chloride with the addition of hydrochloric acid. The resulting Form 1 ranitidine hydrochloride is stable and suitable for producing commercial-scale quantities.

Career Highlights

Aggelos Nikolopoulos is currently employed at Hexal Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the stability and usability of pharmaceutical compounds.

Collaborations

Nikolopoulos collaborates with Helmut Schickaneder, contributing to the innovative environment at Hexal Pharmaceuticals.

Conclusion

Aggelos Nikolopoulos is a prominent figure in pharmaceutical innovation, with a focus on improving the preparation processes of essential compounds. His contributions are vital for the advancement of pharmaceutical chemistry and the production of stable medications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…